Stanozolol has been utilized for weight reduction administration as a part of HIV patients with unending obstructive aspiratory ailment and has demonstrated noteworthy change in weight, body mass file, LBM, and muscle size. Stanozolol has been approved in vitro to altogether improve collagen amalgamation. A constructive outcome of Stanozolol on recuperation in patients with non-mending wounds has additionally been illustrated. Clinical studies demonstrate that the treatment with Stanozolol amid the period of chemotherapy results in a beneficial outcome on the span of cancer-free remission.
Dosage & administration:
Half life
24 hours
Dose
10-200mg per day or as required
Average Cycle Length
4-8 weeks